insulin drugs glp 1 receptor agaonist market GLP-1 Agonist Size & Trends 2035 GLP-1 Receptor Agonist Market Growth
Description
Both GIP and GLP-1 exert direct or indirect effects on adipose and hepatic tissues to regulate lipid and glucose metabolism
Am I a Good Candidate for GLP-1 agonist
doi: 10.18632/oncotarget.13189 87 PinelliNRHurrenKM
Through its dual insulinotropic and glucagonotropic effects on stabilizing glucose levels, GIP could provide a buffer against hyperglycemia when large amounts of glucose are consumed and mitigate reactive hypoglycemia, especially after meals with high fat content
